Retrospective

Daniel N. Hebert (1962–2024)

A glyco-legacy and sweet memories
Ineke Braakman Braakman Maurizio Molinari Reid Gilmore Lila Gierasch
By Ineke Braakman Braakman, Maurizio Molinari, Reid Gilmore and Lila Gierasch
March 17, 2025

When the news spread that Dan Hebert died on Dec. 8, 2024, many colleagues cried. We lost a dear friend and so much more: a true scholar, a colleague and a caring mentor. But above all, a warm friend.

Dan Hebert with his wife, Leah Hebert, on Cape Cod in 2024.
Leah Hebert
Dan Hebert with his wife, Leah Hebert, on Cape Cod in 2024.

Scientifically speaking, Dan’s passion for applying rigorous biochemical experiments to complex cell biological problems was evident early in his career. Dan did his doctoral training with Tony Carruthers at the University of Massachusetts Medical School, obtaining his Ph.D. in 1991. His careful analysis of the oligomeric state of the erythrocyte glucose transporter has stood the test of time. His doctoral training prepared him for his seminal postdoctoral work at the Yale University School of Medicine with Ari Helenius. Through painstaking reconstitutions of secretory protein passage through the endoplasmic reticulum, or ER, Dan was able to map the steps in folding and assembly of complex membrane proteins such as influenza virus hemagglutinin. This work has become the stuff of textbooks such as Molecular Biology of the Cell. It revealed in detail the coupling of protein N-glycosylation, engagement of the lectin chaperones calnexin and calreticulin, disulfide-bond formation and trimerization of this large protein and established an array of tools that could be deployed to accurately follow protein maturation in the cell.

Knowing Dan well, wherever he is now, we imagine him laughing, with a beer in his hand, looking at the four of us writing his obituary. With his humor, Dan would probably start by saying that he used the time spent at Yale soaking up the opportunity to learn from a giant in Helenius, and from there he was inspired to dig and dig to explore in depth the fascinating machineries that regulate protein folding and quality control in the ER of our cells.

In the lab

In his independent research as a faculty member in the biochemistry and molecular biology department at UMass Amherst, the scientific activity of Dan Hebert and his wonderful team was centered on sugars, proteins and their cross talk. A large fraction of the eukaryotic proteome traverses the ER to be secreted from the cell or incorporated into cellular membranes. Most of these proteins are glycosylated at asparagine residues (N in single letter code and hence N-glycosylation). The Hebert lab delivered essential insights into the roles of the highly hydrophilic N-linked glycans composed of two N-acetylglucosamines, nine mannoses and three glucose residues, showing that they do not simply increase the solubility of immature polypeptides in the crowded ER environment. Rather, these sweet appendices are processed by ER-resident glucosidases and glucosyltransferases that remove and add back a glucose to retain immature polypeptides in the chaperone-rich ER environment, thus favor their proper folding program.

Dan and his team described these mechanisms in molecular details and went on to give essential support to models showing that the cellular protein factory uses slow removal of mannose residues to establish when a polypeptide, for one reason or another, is spending too much time in the folding compartment. If a protein fails to become native, it must be removed to give room for the newly synthesized polypeptide chains that continuously enter the folding compartment. Elegantly, old proteins have fewer mannose residues on their N-linked glycans than proteins that just entered the compartment; the older proteins are selected for retro-translocation into the cytoplasm where they are degraded by the ubiquitin proteasome system.

The Hebert lab essentially uncovered the molecular mechanisms by which N-linked glycans act as reporters and handles for region-specific recruitment of molecular chaperones, enzymes and other quality control sorting factors: the glycan code. This code guides the folding, maturation and quality control of the maturing polypeptide in the ER. Over the years, Dan’s work delved ever more deeply into these questions, and he left no stone unturned to understand the principles that mediate recognition by the two quality control glucosidases in the calnexin cycle, UDP-glucose:glycoprotein glucosyl transferases 1 and 2, known as UGGT1 and UGGT2 — their differences and mechanisms of action.

Dan Hebert with colleagues Jeff Brodsky (left) and Jeff Kelly (right) at the 11th International Conference on Calreticulin in New York in 2015.
Jeff Brodsky
Dan Hebert with colleagues Jeff Brodsky (left) and Jeff Kelly (right) at the 11th International Conference on Calreticulin in New York in 2015.

Before Dan’s work, few scientists appreciated the role of N-glycosylation in secretory protein folding and quality control. Researchers considered N-glycosylation one of the posttranslational modifications, but this is misleading because the lion’s share of N-glycosylation in metazoans occurs cotranslationally, when the nascent unfolded polypeptide is translocated into the ER lumen. The cotranslational addition of N-glycans in higher eukaryotes positions these modifications upstream in protein biosynthesis, to aid with early maturation and quality control events governed by, among others, the lectin chaperones calnexin and calreticulin, which recognize specific oligosaccharide structures along with the ER folding gatekeeper, UGGT.

Throughout his work, Hebert had a keen eye for disease relevance, and he contributed substantively to the current understanding of how the processing on N-linked oligosaccharides regulates the retention in the folding ER environment of immature proteins, the selection of native polypeptides for secretion and the targeting of terminally misfolded proteins for dislocation into the cytoplasm for proteasomal degradation. Researchers have now widely accepted that the defective function of these fundamental steps in the ER underlies diabetes, genetic lung disorders, liver cirrhosis, Alzheimer’s and many other protein-folding diseases.

Dan dreamed of elucidating the journey of a secretory protein from its entry into the ER through the translocon to its arrival in a mature, functional state at its proper destination. He wished to relate the ER machinery that relies so heavily on the N-glycan-structure code to fundamental steps in client folding, as researchers have studied in great detail in laboratory purified systems. He appreciated better than most that these processes would incorporate regulatory aspects, organizational impact and specific recognition using both structural and sequence information. He knew and loved the fact that physicochemical principles would shape protein folding landscapes that underlie these complex cellular events. His rigorous experimental strategies laid the groundwork for these dreams to be fulfilled.

Ari Helenius’ group in the 1980s. Dan Hebert on the right, and Helenius in the middle back.
Maurizio Molinari
Ari Helenius’ group in the 1980s. Dan Hebert on the right, and Helenius in the middle back.

Beyond the lab

Dan passed his passion for science, devotion to critical thinking and strict interpretation of well-designed experiments on to his trainees who were fortunate to have such a caring and disciplined mentor guiding their early careers. Many have gone on to influential positions in biotech and pharma industries or academia and government. They carry the torch that Dan passed to them. They also cared deeply about him — all their interactions were imbued with his warmth and humor.

As we cope with the loss of this impactful scholar and true friend, we remember the beers shared around the world after never-ending evening sessions of meetings; the sarcasm; the fights about politics and Roger Federer; the lobsters at Cold Spring Harbor; stories about our children; and lots of emails where science was always mixed with humor, jokes and at least one sentence that showed genuine interest in our well-being, family and life outside the lab.

Dan Hebert in his lab at the University of Massachusetts Amherst in 2001.
University of Massachusetts Amherst biochemistry and molecular biology department
Dan Hebert in his lab at the University of Massachusetts Amherst in 2001.

Dan loved sports. An avid tennis player through college and beyond, he also was loyal and attached to all Boston teams, whatever their level of performance at any given time. As a fan of Roger Federer, whom Dan described as “elegant as the calnexin cycle,” his email exchanges with one of us peaked during Grand Slam matches, especially Wimbledon, Roger’s garden.

It was easy to underestimate Dan — always good natured and stress-free, always finding time for people. Already as a postdoc, he skillfully mastered (and limited) his working hours, which made many wonder how good and dedicated a scientist he was … Until the data poured in, and his papers were accepted in top journals. Then doubt changed into desire, a desire to learn how he did it.

Dan did not find a good work–life balance, he was work–life balance. He had it down: doing the science he loved and doing it excellently, while spending enough time with family and friends, all the while being a great mentor and caring for everyone in his lab. The "how are you" question was always answered with a smile and never with the common response of "busy." Dan had many an admirer for his life artistry.

Colleagues who had the good fortune to rub shoulders with Dan, whether at UMass Amherst or scientific meetings, knew the respect, humor and joy he graced everyone with, whether at the bar, discussing posters at a conference or on walks up New Hampshire mountains. He linked his passion for his science with his bonds with scientists, establishing enduring friendships. To arrive at Dan and Leah Hebert's home was always to experience a warm embrace. Every stay recharged visitors from the day-to-day.

Dan's death came as a shock to many; only few colleagues knew how ill he was. Science was his safe haven and distraction. Giving up was not written in his book. He talked about “one more chemo and then a break to recover.” He continued working and sharing his life with family and friends as if he were healthy. He remained productive and dedicated to advising his trainees in the last seven years, while undergoing chemotherapy. He kept doing science at the highest level and remained "Dan" in every sense.

Dan was sustained and grounded by his deep love for his family. He is survived by his wife of 33 years, Leah (Kelley) Hebert; their son, Dylan, of Oxford, England; and daughter, Shannon, of Boston, Massachusetts. He was very proud of his children, spending many moments throughout the day connecting with them, no matter their location (Dylan has lived in many places around the globe).

Dan’s family and colleagues have established a graduate scholarship award in his memory.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Ineke Braakman Braakman
Ineke Braakman Braakman

Ineke Braakman is Professor at the Science Faculty of Utrecht University, The Netherlands. She met Dan when they both were post-docs in the lab of Ari Helenius at Yale University, sharing a desire to understand (oxidative) glycoprotein folding in the secretory pathway and its regulation. Their friendship reached from Amherst to Utrecht for over 30 years.

Maurizio Molinari
Maurizio Molinari

Maurizio Molinari is a group leader at the Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland and Adjunct Professor at the School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Switzerland. He shared with Dan, during the last 27 years, the love for grasping the mechanisms of glycoprotein folding; quality control and degradation from the endoplasmic reticulum; for beer and for Roger.

Reid Gilmore
Reid Gilmore

Reid Gilmore is retired from the University of Massachusetts Chan Medical School, Worcester, Massachusetts. Reid met Dan when Dan joined the Ph.D. program at UMASS Medical School in 1986, and later Reid served as the chair of Dan's thesis committee. A shared interest in the role of N-linked glycosylation and glycoprotein folding led to many useful discussions during the past 30 years.

Lila Gierasch
Lila Gierasch

Lila Gierasch is distinguished research professor at the University of Massachusetts Amherst, where she worked side-by-side with Dan Hebert after helping to recruit him in 1997. She knew Dan before this and knew that he would bring great science to UMass. He was a close friend and collaborator through their 27 years together at UMass.

Related articles

John H. Exton: A cell signaling pioneer
Roger J. Colbran, Jackie D. Corbin & Alan D. Cherrington
In memoriam: Joel Dain
ASBMB Today Staff

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Daniel N. Hebert
In Memoriam

In memoriam: Daniel N. Hebert

March 17, 2025

He was a professor at the University of Massachusetts Amherst, who discovered the glycan code that facilitates protein folding, maturation and quality control in the endoplasmic reticulum.

Meet Robert Helsley
Interview

Meet Robert Helsley

March 6, 2025

The Journal of Lipid Research junior associate editor studies chronic liver disease and was the first in his family to attend college.

Exploring life’s blueprint: Gene expression in development and evolution
In-person Conference

Exploring life’s blueprint: Gene expression in development and evolution

March 3, 2025

Meet Julia Zeitlinger and David Arnosti — two co-chairs of the ASBMB’s 2025 meeting on gene expression, to be held June 26-29, in Kansas City, Missouri.

ASBMB names 2025 fellows
Announcement

ASBMB names 2025 fellows

Feb. 17, 2025

American Society for Biochemistry and Molecular Biology honors 24 members for their service to the society and accomplishments in research, education, mentorship, diversity and inclusion and advocacy.

When Batman meets Poison Ivy
Science Communication

When Batman meets Poison Ivy

Feb. 13, 2025

Jessica Desamero had learned to love science communication by the time she was challenged to explain the role of DNA secondary structure in halting cancer cell growth to an 8th-grade level audience.

The monopoly defined: Who holds the power of science communication?
Essay

The monopoly defined: Who holds the power of science communication?

Feb. 12, 2025

“At the official competition, out of 12 presenters, only two were from R2 institutions, and the other 10 were from R1 institutions. And just two had distinguishable non-American accents.”